Literature DB >> 1315635

Adrenergic blockade blunts adenosine concentration and coronary vasodilation during hypoxia.

S C Herrmann1, E O Feigl.   

Abstract

Myocardial hypoxia is thought to be an important stimulus for increasing interstitial adenosine concentration. The adenosine hypothesis of coronary control was investigated during steady-state hypoxia by making measurements of coronary venous and epicardial well adenosine concentrations in adrenergically intact dogs and in animals with alpha- and beta-receptor blockade. In the adrenergically intact group, hypoxia sufficient to lower coronary venous oxygen tension to 8 mm Hg increased coronary blood flow 243% from normoxic values. Both coronary venous and epicardial well adenosine concentrations were increased throughout the hypoxic period. In the adrenergically blocked group, hypoxia to a similar level of coronary venous oxygen tension produced an increase in coronary blood flow of only 75%, which was significantly less than in the adrenergically intact group (p less than 0.01). Coronary venous adenosine was only transiently elevated, and epicardial well adenosine was unchanged from control levels. In a separate group of alpha- and beta-receptor-blocked animals that received an infusion of L-homocysteine thiolactone during hypoxia, there was no difference in tissue S-adenosylhomocysteine levels compared with those of normoxic controls. It is concluded that much of the coronary vasodilation associated with systemic hypoxia is dependent on adrenergic activation and that adenosine may only play a role in sustained hypoxic vasodilation when adrenergic receptors are intact.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1315635     DOI: 10.1161/01.res.70.6.1203

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  20 in total

1.  Chaotic behavior of the coronary circulation.

Authors:  Jerome Trzeciakowski; William M Chilian
Journal:  Med Biol Eng Comput       Date:  2008-05       Impact factor: 2.602

Review 2.  Regulation of Coronary Blood Flow.

Authors:  Adam G Goodwill; Gregory M Dick; Alexander M Kiel; Johnathan D Tune
Journal:  Compr Physiol       Date:  2017-03-16       Impact factor: 9.090

3.  N6-(2-hydroxyethyl)-adenosine from Cordyceps cicadae attenuates hydrogen peroxide induced oxidative toxicity in PC12 cells.

Authors:  Leguo Zhang; Tao Wu; Opeyemi Joshua Olatunji; Jian Tang; Yuan Wei; Zhen Ouyang
Journal:  Metab Brain Dis       Date:  2019-06-13       Impact factor: 3.584

Review 4.  Disentangling the Gordian knot of local metabolic control of coronary blood flow.

Authors:  Johnathan D Tune; Adam G Goodwill; Alexander M Kiel; Hana E Baker; Shawn B Bender; Daphne Merkus; Dirk J Duncker
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-11-08       Impact factor: 4.733

Review 5.  It is time to ask what adenosine can do for cardioprotection.

Authors:  M Kitakaze; M Hori
Journal:  Heart Vessels       Date:  1998       Impact factor: 2.037

6.  Cardiac mechanics are impaired during fatiguing exercise and cold pressor test in healthy older adults.

Authors:  Matthew D Muller; Jessica L Mast; Hardikkumar Patel; Lawrence I Sinoway
Journal:  J Appl Physiol (1985)       Date:  2012-11-15

7.  Ecto-5'-nucleotidase is expressed by pericytes and fibroblasts in the rat heart.

Authors:  K Mlodzik; J Loffing; M Le Hir; B Kaissling
Journal:  Histochem Cell Biol       Date:  1995-03       Impact factor: 4.304

8.  Inhibition of adenosine deaminase and administration of adenosine increase hypoxia induced ventricular ectopy.

Authors:  R J Leone; G F Merrill
Journal:  Basic Res Cardiol       Date:  1995 May-Jun       Impact factor: 17.165

9.  The effect of hypoxic myocardial preconditioning is highly dependent on the light-dark cycle in Wistar rats.

Authors:  Pavol Svorc; Roman Benacka
Journal:  Exp Clin Cardiol       Date:  2008

10.  Relation of myocardial oxygen consumption and function to high energy phosphate utilization during graded hypoxia and reoxygenation in sheep in vivo.

Authors:  M A Portman; T A Standaert; X H Ning
Journal:  J Clin Invest       Date:  1995-05       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.